Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of $0.05, $0.09 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $25.83 million versus the consensus estimate of $22.91 million.

GUIDANCE:

Rockwell Medical sees FY2024 revenue of $95-98 million, versus the consensus of $92.493 million.

Adjusted EBITDA: $0.75 to $1.5 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.